APGE R&D Expense Growth
Apogee Therapeutics Inc · R&D Expense Growth
APGE R&D Expense Growth
Latest reported27.91%period ending
APGE FY R&D Growth (YoY) (0.00% → 27.91%)
Latest values, visible window
High-resolution chart · PNG
APGE r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 27.9075% | |
| 145.3306% | |
| 146.2535% | |
| 0% |